Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
272 rows where has_cryoEM = 1, surface_class = "B_cargo" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 272 ✖
surface_class 1
- B_cargo · 272 ✖
has_structure 1
- 1 272
has_cryoEM 1
- 1 · 272 ✖
has_activation_state_pdb_pair 1
- 0 272
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P68133 | ACTA1 | Actin, alpha skeletal muscle | Tier 1.5 | 0.758 | 1 | B_cargo | 5 | 95.12 | 1 | 0 | 0 | 0 | 1 | congenital myopathy 2a, typical, autosomal dominant | 0.8588441418736817 | |||
| P05165 | PCCA | Propionyl-CoA carboxylase alpha chain, mitochondrial | Tier 1.5 | 0.756 | 1 | B_cargo | 25 | 87.44 | 1 | 0 | 1 | 1 | 36578103 | 1 | propionic acidemia | 0.8530542602972598 | ||
| Q14896 | MYBPC3 | Myosin-binding protein C, cardiac-type | Tier 1.5 | 0.755 | 1 | B_cargo | 17 | 78.81 | 1 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy | 0.8502637105703099 | |||
| P30084 | ECHS1 | Enoyl-CoA hydratase, mitochondrial | Tier 1.5 | 0.755 | 1 | B_cargo | 6 | 91.69 | 1 | 0 | 0 | 0 | 1 | mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency | 0.8483381531913922 | |||
| P26440 | IVD | Isovaleryl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.754 | 1 | B_cargo | 5 | 93.38 | 1 | 0 | 1 | 2 | 41230502, 26946282 | 1 | isovaleric acidemia | 0.8480603595890895 | ||
| P35573 | AGL | Glycogen debranching enzyme | Tier 1.5 | 0.75 | 1 | B_cargo | 1 | 92.75 | 1 | 0 | 0 | 0 | 1 | glycogen storage disease III | 0.8321686508777297 | |||
| Q9Y4W6 | AFG3L2 | Mitochondrial inner membrane m-AAA protease component AFG3L2 | Tier 1.5 | 0.75 | 1 | B_cargo | 2 | 76.75 | 1 | 0 | 0 | 0 | 1 | spinocerebellar ataxia type 28 | 0.8341800061294613 | |||
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | Tier 1.5 | 0.748 | 1 | B_cargo | 2 | 86.56 | 1 | 0 | 1 | 1 | 23770039 | 1 | abetalipoproteinemia | 0.8281089516017405 | ||
| Q9Y484 | WDR45 | WD repeat domain phosphoinositide-interacting protein 4 | Tier 1.5 | 0.747 | 1 | B_cargo | 3 | 90.5 | 1 | 0 | 0 | 0 | 1 | neurodegeneration with brain iron accumulation 5 | 0.8230559793277397 | |||
| Q53H12 | AGK | Acylglycerol kinase, mitochondrial | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 87.0 | 1 | 0 | 1 | 1 | 35763566 | 1 | Sengers syndrome | 0.8231275438888749 | ||
| O75027 | ABCB7 | Iron-sulfur clusters transporter ABCB7, mitochondrial | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 78.12 | 1 | 0 | 0 | 0 | 1 | X-linked sideroblastic anemia with ataxia | 0.821045506234113 | |||
| P63267 | ACTG2 | Actin, gamma-enteric smooth muscle | Tier 1.5 | 0.745 | 1 | B_cargo | 4 | 95.38 | 1 | 0 | 0 | 0 | 1 | visceral myopathy 1 | 0.8175814609874555 | |||
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Tier 1.5 | 0.744 | 1 | B_cargo | 10 | 87.25 | 1 | 0 | 1 | 5 | 41290466, 38569854, 31879964, 31702021, 21433395 | 1 | Chronic mucocutaneous candidosis | 0.8147374964880533 | ||
| P51159 | RAB27A | Ras-related protein Rab-27A | Tier 1.5 | 0.744 | 1 | B_cargo | 11 | 83.94 | 1 | 0 | 0 | 0 | 1 | Griscelli syndrome type 2 | 0.8139882966122653 | |||
| Q14839 | CHD4 | ATP-dependent chromatin remodeler CHD4 | Tier 1.5 | 0.743 | 1 | B_cargo | 12 | 64.62 | 1 | 0 | 0 | 0 | 1 | Sifrim-Hitz-Weiss syndrome | 0.8103430577478806 | |||
| Q8TCS8 | PNPT1 | Polyribonucleotide nucleotidyltransferase 1, mitochondrial | Tier 1.5 | 0.743 | 1 | B_cargo | 11 | 87.44 | 1 | 0 | 0 | 0 | 1 | combined oxidative phosphorylation defect type 13 | 0.8091107966912156 | |||
| O43464 | HTRA2 | Serine protease HTRA2, mitochondrial | Tier 1.5 | 0.742 | 1 | B_cargo | 13 | 74.44 | 1 | 0 | 0 | 0 | 1 | 3-methylglutaconic aciduria type 8 | 0.8079136325441377 | |||
| Q14738 | PPP2R5D | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform | Tier 1.5 | 0.742 | 1 | B_cargo | 2 | 79.94 | 1 | 0 | 0 | 0 | 1 | Hogue-Janssens syndrome 1 | 0.8058398703478188 | |||
| Q15125 | EBP | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Tier 1.5 | 0.742 | 1 | B_cargo | 4 | 95.56 | 1 | 0 | 0 | 0 | 1 | MEND syndrome | 0.8082510362309315 | |||
| P43007 | SLC1A4 | Neutral amino acid transporter A | Tier 1.5 | 0.741 | 1 | B_cargo | 1 | 80.56 | 1 | 0 | 1 | 6 | 36219068, 31989939, 27571928, 26811678, 19046328, 16139842 | 1 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.8025684205131692 | ||
| Q14669 | TRIP12 | E3 ubiquitin-protein ligase TRIP12 | Tier 1.5 | 0.739 | 1 | B_cargo | 5 | 66.75 | 1 | 0 | 0 | 0 | 1 | Clark-Baraitser syndrome | 0.795639262535032 | |||
| Q9Y4R8 | TELO2 | Telomere length regulation protein TEL2 homolog | Tier 1.5 | 0.739 | 1 | B_cargo | 3 | 83.88 | 1 | 0 | 0 | 0 | 1 | TELO2-related intellectual disability-neurodevelopmental disorder | 0.7971337980726797 | |||
| P10916 | MYL2 | Myosin regulatory light chain 2, ventricular/cardiac muscle isoform | Tier 1.5 | 0.738 | 1 | B_cargo | 3 | 83.5 | 1 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy | 0.7947577322969279 | |||
| Q14697 | GANAB | Neutral alpha-glucosidase AB | Tier 1.5 | 0.738 | 1 | B_cargo | 2 | 92.94 | 1 | 0 | 0 | 0 | 1 | polycystic kidney disease 3 with or without polycystic liver disease | 0.7928508011740861 | |||
| P98155 | VLDLR | Very low-density lipoprotein receptor | Tier 1.5 | 0.737 | 1 | B_cargo | 27 | 75.69 | 1 | 0 | 1 | 1 | 19188685 | 1 | Dysequilibrium syndrome | 0.790164037509625 | ||
| Q96IJ6 | GMPPA | Mannose-1-phosphate guanylyltransferase regulatory subunit alpha | Tier 1.5 | 0.737 | 1 | B_cargo | 3 | 93.06 | 1 | 0 | 0 | 0 | 1 | Triple A syndrome | 0.7907928491141871 | |||
| O14497 | ARID1A | AT-rich interactive domain-containing protein 1A | Tier 1.5 | 0.734 | 1 | B_cargo | 8 | 46.91 | 1 | 0 | 0 | 0 | 1 | intellectual disability, autosomal dominant 14 | 0.7798204163479697 | |||
| P51790 | CLCN3 | H(+)/Cl(-) exchange transporter 3 | Tier 1.5 | 0.733 | 1 | B_cargo | 5 | 80.0 | 1 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with hypotonia and brain abnormalities | 0.7761855675091979 | |||
| Q15813 | TBCE | Tubulin-specific chaperone E | Tier 1.5 | 0.732 | 1 | B_cargo | 6 | 89.19 | 1 | 0 | 1 | 1 | 34448574 | 1 | hypoparathyroidism-retardation-dysmorphism syndrome | 0.7744447925917005 | ||
| Q2TAL8 | QRICH1 | Transcriptional regulator QRICH1 | Tier 1.5 | 0.729 | 1 | B_cargo | 2 | 57.47 | 1 | 0 | 0 | 0 | 1 | Ververi-Brady syndrome 1 | 0.7633163630733731 | |||
| Q13043 | STK4 | Serine/threonine-protein kinase 4 | Tier 1.5 | 0.728 | 1 | B_cargo | 16 | 75.94 | 1 | 0 | 1 | 1 | 31707227 | 1 | combined immunodeficiency due to STK4 deficiency | 0.7613382040802787 | ||
| O75175 | CNOT3 | CCR4-NOT transcription complex subunit 3 | Tier 1.5 | 0.727 | 1 | B_cargo | 6 | 65.44 | 1 | 0 | 0 | 0 | 1 | intellectual developmental disorder with speech delay, autism and dysmorphic facies | 0.7557397879122256 | |||
| P14854 | COX6B1 | Cytochrome c oxidase subunit 6B1 | Tier 1.5 | 0.724 | 1 | B_cargo | 3 | 95.0 | 1 | 0 | 0 | 0 | 1 | mitochondrial complex IV deficiency, nuclear type 7 | 0.7478662750768209 | |||
| O00400 | SLC33A1 | Acetyl-coenzyme A transporter 1 | Tier 1.5 | 0.723 | 1 | B_cargo | 2 | 82.38 | 1 | 0 | 0 | 0 | 1 | Huppke-Brendel syndrome | 0.7421018006689203 | |||
| P07237 | P4HB | Protein disulfide-isomerase | Tier 1.5 | 0.723 | 1 | B_cargo | 14 | 88.5 | 1 | 0 | 1 | 2 | 31625090, 28952381 | 1 | Cole-Carpenter syndrome | 0.7447295842045853 | ||
| Q63HN8 | RNF213 | E3 ubiquitin-protein ligase RNF213 | Tier 1.5 | 0.723 | 1 | B_cargo | 4 | 86.25 | 1 | 0 | 0 | 0 | 1 | Moyamoya disease | 0.7432964420796212 | |||
| Q9Y287 | ITM2B | Integral membrane protein 2B | Tier 1.5 | 0.72 | 1 | B_cargo | 1 | 75.44 | 1 | 0 | 0 | 0 | 1 | ABri amyloidosis | 0.7342528954076827 | |||
| O95479 | H6PD | GDH/6PGL endoplasmic bifunctional protein | Tier 1.5 | 0.719 | 1 | B_cargo | 1 | 90.56 | 1 | 0 | 0 | 0 | 1 | Hyperandrogenism due to cortisone reductase deficiency | 0.7312443728931738 | |||
| P17812 | CTPS1 | CTP synthase 1 | Tier 1.5 | 0.718 | 1 | B_cargo | 7 | 91.38 | 1 | 0 | 0 | 0 | 1 | combined immunodeficiency due to CTPS1 deficiency | 0.727135118379296 | |||
| Q8TAQ2 | SMARCC2 | SWI/SNF complex subunit SMARCC2 | Tier 1.5 | 0.715 | 1 | B_cargo | 10 | 63.41 | 1 | 0 | 0 | 0 | 1 | Coffin-Siris syndrome 8 | 0.7151553459130683 | |||
| P21281 | ATP6V1B2 | V-type proton ATPase subunit B, brain isoform | Tier 1.5 | 0.715 | 1 | B_cargo | 8 | 86.0 | 1 | 0 | 0 | 0 | 1 | Zimmermann-Laband syndrome 2 | 0.7173813048839504 | |||
| Q02218 | OGDH | 2-oxoglutarate dehydrogenase complex component E1 | Tier 1.5 | 0.715 | 1 | B_cargo | 3 | 90.44 | 1 | 0 | 0 | 0 | 1 | oxoglutaricaciduria | 0.7171952130928542 | |||
| Q8ND04 | SMG8 | Nonsense-mediated mRNA decay factor SMG8 | Tier 1.5 | 0.712 | 1 | B_cargo | 6 | 73.88 | 1 | 0 | 0 | 0 | 1 | Alzahrani-Kuwahara syndrome | 0.705812720697099 | |||
| Q8NI36 | WDR36 | WD repeat-containing protein 36 | Tier 1.5 | 0.712 | 1 | B_cargo | 3 | 87.44 | 1 | 0 | 0 | 0 | 1 | open-angle glaucoma | 0.7050878586165737 | |||
| Q03519 | TAP2 | Antigen peptide transporter 2 | Tier 1.5 | 0.712 | 1 | B_cargo | 21 | 82.69 | 1 | 0 | 0 | 0 | 1 | MHC class I deficiency | 0.7053973274491012 | |||
| Q5MNZ6 | WDR45B | WD repeat domain phosphoinositide-interacting protein 3 | Tier 1.5 | 0.709 | 1 | B_cargo | 5 | 94.81 | 1 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures | 0.6954780252748286 | |||
| Q13158 | FADD | FAS-associated death domain protein | Tier 1.5 | 0.708 | 1 | B_cargo | 18 | 72.12 | 1 | 0 | 1 | 3 | 36309655, 30594071, 26318819 | 1 | FADD-related immunodeficiency | 0.6932338529214827 | ||
| O14979 | HNRNPDL | Heterogeneous nuclear ribonucleoprotein D-like | Tier 1.5 | 0.705 | 1 | B_cargo | 1 | 62.78 | 1 | 0 | 0 | 0 | 1 | autosomal dominant limb-girdle muscular dystrophy type 1G | 0.6837247353165932 | |||
| P31483 | TIA1 | Cytotoxic granule associated RNA binding protein TIA1 | Tier 1.5 | 0.699 | 1 | B_cargo | 10 | 73.69 | 1 | 0 | 0 | 0 | 1 | amyotrophic lateral sclerosis 26 with or without frontotemporal dementia | 0.6625203683612911 | |||
| Q15645 | TRIP13 | Pachytene checkpoint protein 2 homolog | Tier 1.5 | 0.696 | 1 | B_cargo | 6 | 86.69 | 1 | 0 | 0 | 0 | 1 | mosaic variegated aneuploidy syndrome 3 | 0.6540826184796098 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;